Abuse potential of mirogabalin in recreational polydrug users.

"Conflict of interest statement: The author(s) declared following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: JM and HZ are employees of Daiichi Sankyo, Inc. JL and VW were employees of Daiichi Sankyo, Inc. at the time the study was conducted. NLC, ES, DK, and BV received funding to conduct the study."

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by Daiichi Sankyo, Inc., Basking Ridge, NJ. Writing and editorial assistance was provided by Senem Kurtoglu, PhD, MBA, and Claire Daniele, PhD, of AlphaBioCom, LLC, King of Prussia, PA, and supported by Daiichi Sankyo, Inc."